Alisa Wolberg: Thrilled to Have Been Able to Visit the NIH with ASH and Advocate for Science and the Fight 4 Hematology
Alisa Wolberg, Professor at University of North Carolina at Chapel Hill, reposted from ASH on LinkedIn:
”Thrilled to have been able to visit the NIH with ASH last week and advocate for science and the Fight 4 Hematology”
American Society of Hematology (ASH) shared on LinkedIn:
”Last week, ASH leaders went to The National Institutes of Health (NIH) to advocate for blood research.
Drs. Belinda Avalos, Robert Negrin, Jennifer Brown, and Alisa Wolberg met with NIH and NHLBI leaders to discuss critical priorities in hematology.
Key topics included:
- Protecting federal funding for hematology research
- Supporting early-career investigators through the Fight 4 Hematology campaign
- Updates on NIH peer review and other policy changes that impact research and patient care
These conversations are vital for ensuring hematology research continues to advance, patients benefit from breakthroughs, and the next generation of hematologists is supported.
Learn how you can Fight 4 Hematology.”
Stay updated with Hemostasis Today.
-
Apr 6, 2026, 07:14Oliver Tiebel: Antiphospholipid Syndrome in Pregnancy – One of Hematology’s Most Complex Challenges
-
Apr 6, 2026, 06:25Katherine Bridge: My First Time at The EHA ReCon
-
Apr 6, 2026, 06:11Priya Prasad: Family Donations Are Not as Safe as We Usually Think
-
Apr 6, 2026, 05:48Isaac Okello: Turning Point from Reliance on Foreign Exports to Self – Reliance Through Local Production of Medical Supplies
-
Apr 6, 2026, 05:34Lena Volland: Scientific Exchange in Bleeding Disorders at the WFH 2026 World Congress
-
Apr 6, 2026, 04:46Ursula Porage Dona: Bringing the Bleeding Disorders Community Together at WFH 2026 with NNHF
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion
-
Apr 6, 2026, 03:57Isabella Cieri: How TEG Is Transforming Vascular Surgery Care
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients